Riskpilot← Back to searchSign inGet full accessGynRAMa AB
ABActiveOrg 5593688111Anders Personsgatan 12Medical specialists activities · NACE 8622Est. 20225-9 employees
Revenue 2024
SEK 3,4M
+125% vs 2023
EBITDA margin
46.3%
+676% vs 2023
Equity ratio
54.0%
Financial strength
Net profit 2024
SEK 902K
+604% vs 2023
| Revenue | SEK 3,4M | +125% |
| EBITDA | SEK 1,6M | +676% |
| Net profit | SEK 902K | +604% |
| Total assets | SEK 1,9M | +72% |
| Equity | SEK 1M | +625% |
| Employees | — | — |
Legal name
GynRAMa AB
Org number
5593688111
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
4 mars 2022
Share capital
SEK 25 000
Employees
5-9
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Aktiebolaget ska bedriva sjukvård, utbildning, författarskap och föreläsningar inom sjukvård, utförande av försäkringsmedicinska bedömningar, konsultation inom medicin och forskning samt innehav och förvaltning av fast och lös egendom och därmed förenlig verksamhet.
Address
Anders Personsgatan 12
Email
randaakouri@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 180 | 0 | 1 529 | 3 440 |
| Staff expenses | — | −0 | −155 | −723 |
| EBITDA | −17 | 0 | 205 | 1 593 |
| Depreciation & amort. | −25 | −0 | −54 | −54 |
| EBIT | −42 | 0 | 151 | 1 539 |
| Net financials | −5 | 0 | −2 | −1 |
| Profit before tax | −47 | 0 | 149 | 1 145 |
| Tax | −0 | −0 | −21 | −243 |
| Net profit | −47 | 0 | 128 | 902 |
| Item | 2022 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 553 | 553 | 1 098 | 1 891 |
| Equity | 13 | 13 | 141 | 1 022 |
| Long-term debt | 0 | 0 | — | — |
| Short-term debt | 540 | 540 | 957 | 476 |
| Total debt | 540 | 540 | 957 | 476 |
EBITDA margin
46.3%
This company
15.8%
Market median
+193% vs market
20222024
Equity ratio
54.0%
This company
38.2%
Market median
+41% vs market
20222024
Return on equity
88.3%
This company
18.4%
Market median
+380% vs market
20222024
Net profit margin
26.2%
This company
8.1%
Market median
+223% vs market
20222024
Asset turnover
1.82×
This company
1.12×
Market median
+62% vs market
20222024
Debt / equity
0.85×
This company
0.62×
Market median
+37% vs market
20222024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-03-04 – 2022-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-03-01 – 2022-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Audit | 2025 | |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
| Former (2) | ||
| Deputy Board Member | 2022 – 2024 | |
| Board of Directors | 2022 – 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2025 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Akouri Health Care AB
GynRAMa AB Board members of GynRAMa AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Alf Niclas Ljunggren-Weidmann | Audit | 0 companies |
| Randa Akouri | Board of Directors | 0 companies |
| Siri Margrethe Brännström | Deputy Board Member | 0 companies |
| Michel Akouri | Deputy Board Member | 0 companies |
| Mats Börje Brännström | Board of Directors | 0 companies |